Vincent Liptak

Vincent Liptak, J.D., Ph.D., M.B.A. is General Counsel and Executive Vice President of BlossomHill Therapeutics, Inc. Vince has over 20 years of experience in the legal profession, with a focus on intellectual property. Prior to joining BlossomHill, Vince was a partner at Barnes & Thornburg, LLP, serving as outside counsel for many clients in the chemical and life sciences space. While at Barnes & Thornburg, Vince served as a co-Chair for the firm’s Life Sciences Practice Group. With pharmaceutical patents as his practice focus, Vince has written hundreds of patents covering various aspects of pharmaceutical compounds, including patents covering several FDA-approved products. Vince has worked with BlossomHIll’s Scientific Founder, President and CEO, Dr. J. Jean Cui for over 18 years, beginning together as colleagues at Pfizer, Inc in La Jolla, CA. Over the course of his career, Vince has written the patents that cover crizotinib (Xalkori®), lorlatinib (Lobrena®), repotrectinib, elzovantinib, as well as other compounds discovered by Dr. Cui and her colleagues at Pfizer, Turning Point Therapeutics, Inc., and BlossomHill.

Vince received a B.S. with a double major in chemistry and mathematics from Loyola University Chicago. He went on to receive his M.S. and Ph.D. degrees from The University of Chicago. Before entering the legal profession, Vince was a post-doc in the laboratory of Prof. Dennis Dougherty at California Institute of Technology in Pasadena, CA. After a few years working as a patent agent, Vince received a J.D. and an M.B.A. from the University of San Diego. Vince is a member of the California and Indiana bars and is registered to practice before the United States Patent and Trademark Office.